Try

Legend Biotech Corp

LEGNUnited States

19 filed reports · 448 financial concepts · 2 earnings calls · 0 media appearances

Filed reports

19 reports · Dec 2020 to Jun 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 315 interim figures.

Report typeReportsFactsPeriods
Interim · 6-KSEC EDGAR122,143Jun 2021 to Jun 2026
Annual · 20-FSEC EDGAR62,603Dec 2020 to Dec 2025
Annual · 20-F/ASEC EDGAR1380Dec 2021

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q26-KJun 30, 2026Aug 11, 2026321Open
FY2026 Q16-KMar 31, 2026May 12, 2026224Open
FY202520-FDec 31, 2025Mar 10, 2026912Open
FY2025 Q46-KDec 31, 2025Mar 10, 20266Open
FY2025 Q36-KSep 30, 2025Nov 12, 2025260Open
FY2025 Q26-KJun 30, 2025Aug 11, 2025195Open
FY2025 Q16-KMar 31, 2025May 13, 2025195Open
FY202420-FDec 31, 2024Mar 11, 2025559Open
FY2024 Q36-KSep 30, 2024Nov 12, 2024177Open
FY2024 Q26-KJun 30, 2024Aug 9, 2024160Open
FY2024 Q16-KMar 31, 2024May 13, 2024207Open
FY202320-FDec 31, 2023Mar 19, 2024388Open

Financial data

448 concepts · 5,126 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial426 concepts · 4,831 facts · Dec 2017 to Jun 2026

  • Time deposits93 · Dec 2019 to Jun 2026
  • Revenue46 · Dec 2018 to Jun 2026
  • Cash and cash equivalents33 · Dec 2017 to Jun 2026
  • Equity33 · Dec 2017 to Jun 2026
  • Cash and cash equivalents as stated in the statement of financial position31 · Dec 2018 to Jun 2026
  • Cash (IFRS)31 · Dec 2018 to Jun 2026
  • Shortterm deposits classified as cash equivalents31 · Dec 2018 to Jun 2026
  • Cash and cash equivalents as stated in the statement of cash flows29 · Dec 2018 to Dec 2025
  • Other reserves (IFRS)27 · Dec 2019 to Jun 2026
  • Property plant and equipment27 · Dec 2018 to Jun 2026
  • Rightofuse assets27 · Dec 2018 to Jun 2026
  • Assets (IFRS)25 · Dec 2019 to Jun 2026
  • Current assets25 · Dec 2019 to Jun 2026
  • Current lease liabilities (IFRS)25 · Dec 2019 to Jun 2026
  • Current liabilities25 · Dec 2019 to Jun 2026
  • Current prepayments and other current assets25 · Dec 2019 to Jun 2026
  • Current trade receivables25 · Dec 2019 to Jun 2026
  • Equity and liabilities25 · Dec 2019 to Jun 2026
  • Inventories25 · Dec 2019 to Jun 2026
  • Issued capital25 · Dec 2019 to Jun 2026
  • Liabilities (IFRS)25 · Dec 2019 to Jun 2026
  • Noncurrent assets (IFRS)25 · Dec 2019 to Jun 2026
  • Noncurrent lease liabilities (IFRS)25 · Dec 2019 to Jun 2026
  • Noncurrent liabilities25 · Dec 2019 to Jun 2026

Geography17 concepts · 273 facts · Dec 2018 to Jun 2026

  • Revenue57 · Dec 2018 to Sep 2025
  • Applicable tax rate51 · Dec 2018 to Dec 2025
  • Collaboration revenue30 · Dec 2021 to Jun 2026
  • Deferred tax expense income30 · Dec 2019 to Dec 2025
  • United States25 · Dec 2019 to Dec 2025
  • Current tax relating to items charged or credited directly to equity18 · Dec 2018 to Dec 2025
  • License and other revenue - total14 · Dec 2023 to Jun 2026
  • Accounting profit12 · Dec 2019 to Dec 2025
  • China11 · Dec 2020 to Dec 2025
  • Hong Kong7 · Dec 2019 to Dec 2025
  • Ireland7 · Dec 2019 to Dec 2025
  • At the statutory blended income tax rate3 · Dec 2018 to Dec 2020
  • United States of America3 · Dec 2022 to Dec 2024
  • New Jersey2 · Dec 2021 to Dec 2022
  • Deferred tax expense income recognised in profit or loss1 · Dec 2024
  • License revenue1 · Dec 2022
  • Revenue from contracts with customers1 · Dec 2022

Product5 concepts · 22 facts · Dec 2018 to Dec 2021

  • License revenue6 · Dec 2018 to Dec 2021
  • Revenue from performance obligations satisfied or partially satisfied in previous periods6 · Dec 2019 to Dec 2021
  • JSC service4 · Dec 2018 to Dec 2021
  • Revenue that was included in contract liability balance at beginning of period4 · Dec 2018 to Dec 2021
  • Legend Ireland2 · Dec 2020 to Dec 2021

Segments

295 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement geographical14 members · 157 facts

  • US54 · Dec 2019 to Jun 2026
  • CN36 · Dec 2018 to Mar 2026
  • Cn11 · Mar 2024 to Sep 2025
  • Us11 · Mar 2024 to Sep 2025
  • Europe10 · Dec 2021 to Sep 2025
  • Outside The United States Of America9 · Dec 2023 to Jun 2026
  • HK7 · Dec 2019 to Dec 2025
  • IE7 · Dec 2019 to Dec 2025
  • North America3 · Dec 2018 to Dec 2020
  • Other Countries3 · Dec 2020 to Dec 2022
  • NL2 · Dec 2019 to Dec 2020
  • North america2 · Jun 2020 to Jun 2021
  • BE1 · Dec 2021
  • US And Non US Territories1 · Dec 2022

Geographical areas9 members · 116 facts

  • HK25 · Dec 2019 to Dec 2025
  • IE21 · Dec 2019 to Dec 2025
  • US21 · Dec 2018 to Dec 2025
  • CN14 · Dec 2018 to Dec 2025
  • BE10 · Dec 2021 to Dec 2025
  • NJ9 · Dec 2019 to Dec 2025
  • Other Than US7 · Dec 2018 to Dec 2024
  • NL6 · Dec 2018 to Dec 2020
  • Other Than U.S.3 · Dec 2023 to Dec 2025

Products and services2 members · 22 facts

  • Joint Steering Committee Service13 · Dec 2018 to Dec 2021
  • Licensing Of Intellectual Property9 · Dec 2018 to Dec 2021

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

2 calls · May 2026 to Aug 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q2Aug 11, 2026
  • FY2026 Q1May 12, 2026

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.

Legend Biotech Corp (LEGN) data · FactIQ